TickerFacts.

Kestra Medical Technologies, Ltd. (KMTS): Revenue

Annual figures by period end, from SEC filings.

$95.13M
Year ended 2026-04-30
$106.73M
Trailing 12 months to 2026-07-31
2024-04-30: $27.81M2025-04-30: $59.81M2026-04-30: $95.13M$95.13M
2024-04-30 Revenue (USD) 2026-04-30
Period endedRevenueChange YoYSource filing
2026-04-30$95.13M+59.0%2026-07-14, From 2025-05-01
2025-04-30$59.81M+115.1%2026-07-14, From 2024-05-01
2024-04-30$27.81Mn/a2025-07-17, From 2023-05-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$95.13M+59.0%
NeuroPace Inc (NPCE)2025-12-31$99.99M+25.1%
Pulmonx Corp (LUNG)2025-12-31$90.50M+8.0%
Beta Bionics, Inc. (BBNX)2025-12-31$100.25M+53.9%
Delcath Systems, Inc. (DCTH)2025-12-31$85.23M+129.1%
Iradimed Corp (IRMD)2025-12-31$83.81M+14.4%
TELA Bio, Inc. (TELA)2025-12-31$80.28M+15.8%
Anika Therapeutics, Inc. (ANIK)2025-12-31$112.82M-5.9%
Orasure Technologies Inc (OSUR)2025-12-31$115.02M-38.1%

Compare KMTS, NPCE, LUNG, BBNX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗